US6555692B1
(en)
*
|
1996-02-26 |
2003-04-29 |
California Institute Of Technology |
Preparation and use of bifunctional molecules having DNA sequence binding specificity
|
SE9601318D0
(sv)
*
|
1996-04-04 |
1996-04-04 |
Pharmacia Biosensor Ab |
Method for nucleic acid analysis
|
US6046004A
(en)
*
|
1997-02-27 |
2000-04-04 |
Lorne Park Research, Inc. |
Solution hybridization of nucleic acids with antisense probes having modified backbones
|
US6251591B1
(en)
*
|
1997-02-27 |
2001-06-26 |
Lorne Park Research, Inc. |
Quantitative method for detecting nucleotide concentration
|
US6485901B1
(en)
*
|
1997-10-27 |
2002-11-26 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to linear beacons
|
EP1025120B1
(fr)
*
|
1997-10-27 |
2010-08-18 |
Boston Probes, Inc. |
Procedes, trousses et compositions ayant trait a des balises moleculaires de pna (acide nucleique peptidique)
|
WO1999049293A2
(fr)
|
1998-03-24 |
1999-09-30 |
Boston Probes, Inc. |
Procedes, kits et compositions se rapportant a des complexes de detection
|
US6403313B1
(en)
*
|
1999-12-21 |
2002-06-11 |
Ingeneus Corporation |
Fluorescent intensity assay for duplex and triplex nucleic acid hybridization solution utilizing fluorescent intercalators
|
US6858390B2
(en)
|
1998-12-31 |
2005-02-22 |
Ingeneus Corporation |
Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes
|
US6656692B2
(en)
*
|
1999-12-21 |
2003-12-02 |
Ingeneus Corporation |
Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
|
US6420115B1
(en)
|
1999-12-21 |
2002-07-16 |
Ingeneus Corporation |
Cation mediated triplex hybridization assay
|
US6294333B1
(en)
*
|
1998-12-31 |
2001-09-25 |
Ingeneus Corp. |
Fluorescent intensity assay for protein or peptide binding to nucleic acids
|
US6838444B1
(en)
|
1999-06-01 |
2005-01-04 |
Baylor College Of Medicine |
Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
|
WO2000079009A2
(fr)
|
1999-06-22 |
2000-12-28 |
Invitrogen Corporation |
Amorces et procedes ameliores destines a la detection et a la discrimination d'acides nucleiques
|
US6645733B1
(en)
|
1999-06-25 |
2003-11-11 |
Ingeneus Corporation |
Fluorescent intensity method for assaying binding between proteins or peptides
|
US6830902B1
(en)
|
1999-07-02 |
2004-12-14 |
Invitrogen Corporation |
Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
|
WO2001038585A2
(fr)
*
|
1999-11-24 |
2001-05-31 |
The Regents Of The University Of California |
Matrices polymeres et procedes d'utilisation de molecules de sondes marquees pour identifier et quantifier l'expression des molecules cibles
|
US6927027B2
(en)
|
1999-12-21 |
2005-08-09 |
Ingeneus Corporation |
Nucleic acid multiplex formation
|
US20030181412A1
(en)
*
|
1999-12-21 |
2003-09-25 |
Ingeneus Corporation |
Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses
|
US6911536B1
(en)
|
1999-12-21 |
2005-06-28 |
Ingeneus Corporation |
Triplex and quadruplex catalytic hybridization
|
US7052844B2
(en)
*
|
1999-12-21 |
2006-05-30 |
Ingeneus, Inc. |
Purification of DS-DNA using heteropolymeric capture probes and a triplex, quadruplex or homologous duplex binding mechanism
|
US7309569B2
(en)
*
|
1999-12-21 |
2007-12-18 |
Ingeneus, Inc. |
Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
|
US6924108B2
(en)
*
|
1999-12-21 |
2005-08-02 |
Ingeneus Corporation |
Nucleic acid binding enhancement by conjugation with nucleotides, nucleosides, bases and/or their analogues
|
US20030170659A1
(en)
*
|
2000-01-24 |
2003-09-11 |
Ingeneus Corporation |
Electrical treatment of binding media to encourage, discourage and/or study biopolymer binding
|
US7220541B2
(en)
|
2000-01-24 |
2007-05-22 |
Ingeneus, Inc. |
Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions
|
US6613524B1
(en)
|
2000-01-24 |
2003-09-02 |
Ingeneus Corporation |
Amperometric affinity assay and electrically stimulated complexes of nucleic acids
|
US6265170B1
(en)
|
2000-01-24 |
2001-07-24 |
Ingeneus Corporation |
Homogenous assay of duplex of triplex hybridization by means of multiple measurements under varied conditions
|
US6982147B2
(en)
*
|
2000-01-24 |
2006-01-03 |
Ingeneus Corporation |
Apparatus for assaying biopolymer binding by means of multiple measurements under varied conditions
|
US6936443B2
(en)
*
|
2000-04-03 |
2005-08-30 |
Cytyc Corporation |
Detection and typing of human papillomavirus using PNA probes
|
EP1294939B1
(fr)
*
|
2000-04-03 |
2010-01-27 |
Cytyc Corporation |
Detection et typage du papillomavirus humain a l'aide de sondes de proteines pna
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
US20030165859A1
(en)
|
2001-10-23 |
2003-09-04 |
Invitrogen Corporation |
Primers and methods for the detection and discrimination of nucleic acids
|
DE10155031A1
(de)
*
|
2001-11-09 |
2003-05-28 |
Friz Biochem Gmbh |
Fluoreszenz-Quenchen zur Detektion von Ligat-Ligand Assoziationsereignissen in elektrischen Feldern
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
US20030166282A1
(en)
|
2002-02-01 |
2003-09-04 |
David Brown |
High potency siRNAS for reducing the expression of target genes
|
ATE529512T1
(de)
|
2002-02-01 |
2011-11-15 |
Life Technologies Corp |
Doppelsträngige oligonukleotide
|
US6818420B2
(en)
|
2002-02-27 |
2004-11-16 |
Biosource International, Inc. |
Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
|
EP1578396A4
(fr)
|
2002-08-12 |
2007-01-17 |
David Kirn |
Procedes et compositions concernant les poxvirus et le cancer
|
US20040180345A1
(en)
*
|
2003-03-14 |
2004-09-16 |
Ingeneus Corporation |
Pre-incubation method to improve signal/noise ratio of nucleic acid assays
|
WO2006031955A2
(fr)
|
2004-09-14 |
2006-03-23 |
The Regents Of The University Of Colorado, A Body Corporate |
Procede de traitement faisant intervenir du bucindolol fonde sur le ciblage genetique
|
CA2581087C
(fr)
*
|
2004-09-24 |
2013-11-19 |
Ingeneus Inc. |
Analyse genomique
|
JP2006254784A
(ja)
*
|
2005-03-17 |
2006-09-28 |
Institute Of Physical & Chemical Research |
プライマーダイマーからの非特異的増幅を減少させる方法
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
CA2621982C
(fr)
|
2005-09-07 |
2017-11-28 |
Jennerex Biotherapeutics Ulc |
Traitement systemique de cancers metastasiques et/ou systemiquement dissemines a l'aide de poxvirus exprimant le gm-csf
|
ATE378427T1
(de)
*
|
2005-10-17 |
2007-11-15 |
Rina Netzwerk Rna Technologien |
Verfahren zur bestimmung einer unbekannten pns seqenz und seine verwendungen
|
JP5606067B2
(ja)
|
2006-09-15 |
2014-10-15 |
オタワ ホスピタル リサーチ インスティテュート |
腫瘍崩壊性ラブドウイルス
|
US8929630B2
(en)
|
2009-03-27 |
2015-01-06 |
Life Technologies Corporation |
Systems and methods for assessing images
|
CA2766351C
(fr)
|
2009-06-29 |
2018-02-27 |
Luminex Corporation |
Amorces chimeriques avec conformations en epingle a cheveux et procedes d'utilisation de celles-ci
|
US9409983B2
(en)
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
WO2011032088A1
(fr)
|
2009-09-11 |
2011-03-17 |
Arca Biopharma, Inc. |
Polymorphismes dans le gène pde3a
|
WO2011032180A1
(fr)
|
2009-09-14 |
2011-03-17 |
Jennerex, Inc. |
Polythérapie anticancéreuse à virus de la vaccine oncolytique
|
EP2510088B1
(fr)
|
2009-12-10 |
2016-10-05 |
Ottawa Hospital Research Institute |
Rhabdovirus oncolitique
|
ES2587191T3
(es)
|
2009-12-23 |
2016-10-21 |
Arca Biopharma, Inc. |
Métodos y composiciones para enfermedades y afecciones cardiovasculares
|
AU2012204467B2
(en)
|
2011-01-04 |
2016-08-18 |
Sillajen, Inc. |
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
|
EP2681566A2
(fr)
|
2011-02-28 |
2014-01-08 |
University of Iowa Research Foundation |
Changements d'hormone antimullérienne dans la grossesse et prédiction d'évolution indésirable de grossesse et du sexe
|
WO2012120377A2
(fr)
|
2011-03-08 |
2012-09-13 |
King Abdullah University Of Science And Technology |
Biomarqueur moléculaire destiné à la détection précoce du cancer des ovaires
|
EP2718427B1
(fr)
|
2011-06-08 |
2017-01-11 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
Compositions pour le traitement du glioblastome
|
RU2483049C2
(ru)
*
|
2011-07-21 |
2013-05-27 |
Открытое акционерное общество "Научно-исследовательский институт полимерных материалов" |
Способ изготовления партии многошашечных зарядов твердого ракетного топлива
|
WO2013036799A2
(fr)
|
2011-09-09 |
2013-03-14 |
Fred Hutchinson Cancer Research Center |
Procédés et compositions impliquant des inhibiteurs du nkg2d et le cancer
|
WO2014116721A1
(fr)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Vecteur geminiviral pour l'expression du rituximab
|
RU2684211C2
(ru)
|
2013-02-21 |
2019-04-04 |
Тёрнстоун Лимитед Партнершип |
Композиция вакцины
|
US20150098940A1
(en)
|
2013-10-03 |
2015-04-09 |
Oklahoma Medical Research Foundation |
Biomarkers for Systemic Lupus Erythematosus Disease Activity, and Intensity and Flare
|
US20180057839A1
(en)
|
2014-11-26 |
2018-03-01 |
The Regents Of The University Of California |
Therapeutic compositions comprising transcription factors and methods of making and using the same
|
AU2016324165B2
(en)
|
2015-09-16 |
2020-07-02 |
PetaOmics, Inc. |
Methods and compositions for genomic target enrichment and selective DNA sequencing
|
AU2018213315A1
(en)
|
2017-01-26 |
2019-07-25 |
Oklahoma Medical Research Foundation |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
EP3867645B1
(fr)
|
2018-10-18 |
2024-06-05 |
Oklahoma Medical Research Foundation |
Biomarqueurs d'indice immunitaire d'activité de maladie du lupus érythémateux disséminé (sle) qui caractérise une activité de maladie
|
US11733242B2
(en)
|
2018-10-31 |
2023-08-22 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Biomarkers and methods of use for radiation-induced lung injury
|